147 related articles for article (PubMed ID: 27139494)
1. A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat.
Jäger MD; Vondran FW; Ramackers W; Röseler T; Schlitt HJ; Bektas H; Klempnauer J; Timrott K
PLoS One; 2016; 11(5):e0154682. PubMed ID: 27139494
[TBL] [Abstract][Full Text] [Related]
2. In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody.
Dahlke MH; Lauth OS; Jäger MD; Roeseler T; Timrott K; Jackobs S; Neipp M; Wonigeit K; Schlitt HJ
Blood; 2002 May; 99(10):3566-72. PubMed ID: 11986209
[TBL] [Abstract][Full Text] [Related]
3. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
[TBL] [Abstract][Full Text] [Related]
4. T-cell depletion of allogeneic bone marrow using anti-alphabetaTCR monoclonal antibody: prevention of graft-versus-host disease without affecting engraftment potential in rats.
Neipp M; Exner BG; Maru D; Haber M; Gammie JS; Pham SM; Ildstad ST
Exp Hematol; 1999 May; 27(5):860-7. PubMed ID: 10340402
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
Zhu ZX; Fan LY; Wang Q
Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
[TBL] [Abstract][Full Text] [Related]
7. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
8. Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man.
Brenner MK; Wulf GG; Rill DR; Luo KL; Goodell MA; Mei Z; Kuehnle I; Brown MP; Pule M; Heslop HE; Krance RA
Ann N Y Acad Sci; 2003 May; 996():80-8. PubMed ID: 12799286
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation.
Wulf GG; Luo KL; Goodell MA; Brenner MK
Blood; 2003 Mar; 101(6):2434-9. PubMed ID: 12433683
[TBL] [Abstract][Full Text] [Related]
10. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
Tomita Y; Sachs DH; Sykes M
Blood; 1994 Feb; 83(4):939-48. PubMed ID: 7906567
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.
Orozco JJ; Kenoyer A; Balkin ER; Gooley TA; Hamlin DK; Wilbur DS; Hylarides MD; Frost SH; Mawad R; O'Donnell P; Sandmaier BM; Fuchs EJ; Luznik L; Green DJ; Gopal AK; Press OW; Pagel JM
Blood; 2016 Jan; 127(3):352-9. PubMed ID: 26576864
[TBL] [Abstract][Full Text] [Related]
12. CD45 congenic bone marrow transplantation: evidence for T cell-mediated immunity.
Xu H; Exner BG; Chilton PM; Schanie C; Ildstad ST
Stem Cells; 2004; 22(6):1039-48. PubMed ID: 15536194
[TBL] [Abstract][Full Text] [Related]
13. Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation.
Chen Y; Kornblit B; Hamlin DK; Sale GE; Santos EB; Wilbur DS; Storer BE; Storb R; Sandmaier BM
Blood; 2012 Feb; 119(5):1130-8. PubMed ID: 22134165
[TBL] [Abstract][Full Text] [Related]
14. Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice.
Peake K; Manning J; Lewis CA; Barr C; Rossi F; Krieger C
J Vis Exp; 2015 Apr; (98):e52553. PubMed ID: 25867947
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of CD45 antigen in transplantation tolerance.
Ko S; Jaeger MD; Dahlke MH; Nakajima Y; Schlitt HJ
Curr Mol Med; 2002 May; 2(3):249-55. PubMed ID: 12041728
[TBL] [Abstract][Full Text] [Related]
16. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
17. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
[TBL] [Abstract][Full Text] [Related]
18. The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation.
Barsoukov AA; Moore PF; Storb R; Santos EB; Sandmaier BM
Transplantation; 1999 May; 67(10):1329-35. PubMed ID: 10360586
[TBL] [Abstract][Full Text] [Related]
19. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
